Records 1 - 22
| Evaluation of COMT Gene rs4680 Polymorphism as a Risk Factor for Endometrial Cancer.
Indian journal of clinical biochemistry : IJCB 2020 Jan 35 (1): 63-71.
Kumar Pradeep, Singh Garima, Rai Vanda
| Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.
Journal of genetics 2018 Jun 97 (2): 523-537.
Hussain Tajamul, Alrokayan Salman, Upasna Upadhyay, Pavithrakumari Manickam, Jayapriya Jaganathan, Kutala Vijay Kumar, Naushad Shaik Mohamm
| Impact of Catechol-O-Methyltransferase Val 158Met (rs4680) Polymorphism on Breast Cancer Susceptibility in Asian Population
Asian Pacific journal of cancer prevention : APJCP 2017 05 18 (5): 1243-1250.
Rai Vandana, Yadav Upendra, Kumar Prade
| Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
The International journal of biological markers 2016 May 31 (2): e110-7.
Chen Yang, Yu Xiaoxiang, Li Tianyu, Yan Haibiao, Mo Zengn
| Association between the COMT 158 G/A polymorphism and lung cancer risk: a meta-analysis.
International journal of clinical and experimental medicine 2015 8 (10): 17739-47.
Peng Shifeng, Tong Xiang, Liu Sitong, Feng Yulin, Fan Ho
| The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis.
Journal of breast cancer 2014 Jun 17 (2): 149-56.
Wan Guo-Xing, Cao Yu-Wen, Li Wen-Qin, Li Yu-Cong, Li Fe
| Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 2343-50.
Li Kai, Li Wusheng, Zou Huaw
| Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Diagnostic pathology 2014 9 192.
Tan Xiang, Chen Ming
| Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.
PloS one 2014 9 (12): e115869.
Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan, Te Loo Maroeska W
| Lack of association between the COMT rs4680 polymorphism and ovarian cancer risk: evidence from a meta-analysis of 3,940 individuals.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (18): 7941-5.
Du Jin-Ze, Dong Yu-Ling, Wan Guo-Xing, Tao Lin, Lu Li-Xia, Li Feng, Pang Li-Juan, Jia W
| Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6181-6.
Liu Jin-Xin, Luo Rong-Cheng, Li Rong, Li Xia, Guo Yu-Wu, Ding Da-Peng, Chen Yi-Z
| The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec .
Tian C, Liu L, Yang X, Wu H, Ouyang Q
| The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Molecular biology reports 2013 Feb 40 (2): 1835-41.
Xiao Li, Tong Ming, Jin Yanyang, Huang Weichao, Li Ziz
| Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013 Jan .
Teng Y, He C, Zuo X, Li X
| No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Genetic testing and molecular biomarkers 2013 Jan 17 (1): 78-84.
Zou Li-wei, Xu Xiao-juan, Liu Ting, Wang Han-yong, Fan Wen-jing, Wang Xing-hua, Zhang Zhao-xiang, Zhai Jin-x
| Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Genetics and molecular research : GMR 2013 12 (4): 6442-53.
Lin G, Zhao J, Wu J, Andreevich O R, Zhang W-H, Zhang Y, Yu
| Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Urologia internationalis 2012 Dec .
Zhang H, Zhang Z, Wu J, Xu Y, Cheng R, Li L
| Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Diagnostic pathology 2012 Oct 7 (1): 1.
Qin X, Peng Q, Qin A, Chen Z, Lin L, Deng Y, Xie L, Xu J, Li H, Li T, Li S, Zhao J
| Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.
Molecular biology reports 2012 Jun 39 (6): 6811-23.
He Xiao-Feng, Wei Wu, Li Shao-Xia, Su Jiao, Zhang Ying, Ye Xiang-Hua, Liu Yi, Wang W
| COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
Breast cancer research and treatment 2010 Aug 123 (1): 265-70.
Ding Haixia, Fu Yuanyuan, Chen Weixian, Wang Zhanw
| Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.
Breast cancer research and treatment 2010 Jun 121 (3): 719-25.
Mao Chen, Wang Xi-Wen, Qiu Li-Xin, Liao Ru-Yan, Ding Hong, Chen Qi
| Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Feb 14 (2): 329-35.
Wen Wanqing, Cai Qiuyin, Shu Xiao-Ou, Cheng Jia-Rong, Parl Fritz, Pierce Larry, Gao Yu-Tang, Zheng W